TABLE 4.

miRNAs differently expressed according to clinical outcome at 3 months.

	FC	p-value	q-value
hsa-miR-451a	8.6692	0.021018	0.99993
hsa-miR-1246	2.238	0.021301	0.99993
hsa-miR-144-3p	4.9203	0.033741	0.99993
hsa-miR-630	2.7222	0.042347	0.99993

The table shows fold change (FC) of miRNAs comparing poor (mRS > 2) vs. good (mRS 0-2) clinical outcome at 3 months, the raw p-value (p-value), and the p-value adjusted by FDR (q-value). T-test student was performed to obtain the raw p-value and FDR correction to obtain the p-value adjusted (q-value).